BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quinzii CM, Hirano M. Primary and secondary CoQ(10) deficiencies in humans. Biofactors 2011;37:361-5. [PMID: 21990098 DOI: 10.1002/biof.155] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Hekimi S. Micellization of coenzyme Q by the fungicide caspofungin allows for safe intravenous administration to reach extreme supraphysiological concentrations. Redox Biol 2020;36:101680. [PMID: 32810741 DOI: 10.1016/j.redox.2020.101680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Fernández-Del-Río L, Nag A, Gutiérrez Casado E, Ariza J, Awad AM, Joseph AI, Kwon O, Verdin E, de Cabo R, Schneider C, Torres JZ, Burón MI, Clarke CF, Villalba JM. Kaempferol increases levels of coenzyme Q in kidney cells and serves as a biosynthetic ring precursor. Free Radic Biol Med 2017;110:176-87. [PMID: 28603085 DOI: 10.1016/j.freeradbiomed.2017.06.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
3 Cornelius N, Byron C, Hargreaves I, Guerra PF, Furdek AK, Land J, Radford WW, Frerman F, Corydon TJ, Gregersen N, Olsen RK. Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple Acyl-CoA dehydrogenation deficiency. Hum Mol Genet 2013;22:3819-27. [PMID: 23727839 DOI: 10.1093/hmg/ddt232] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
4 Modelli A, Pshenichnyuk SA. Gas-phase dissociative electron attachment to flavonoids and possible similarities to their metabolic pathways. Phys Chem Chem Phys 2013;15:1588-600. [PMID: 23243660 DOI: 10.1039/c2cp43379f] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
5 Dard L, Blanchard W, Hubert C, Lacombe D, Rossignol R. Mitochondrial functions and rare diseases. Mol Aspects Med 2020;71:100842. [PMID: 32029308 DOI: 10.1016/j.mam.2019.100842] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
6 Navas P, Cascajo MV, Alcázar-Fabra M, Hernández-Camacho JD, Sánchez-Cuesta A, Rodríguez ABC, Ballesteros-Simarro M, Arroyo-Luque A, Rodríguez-Aguilera JC, Fernández-Ayala DJM, Brea-Calvo G, López-Lluch G, Santos-Ocaña C. Secondary CoQ10 deficiency, bioenergetics unbalance in disease and aging. Biofactors 2021;47:551-69. [PMID: 33878238 DOI: 10.1002/biof.1733] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li M, Yue Z, Lin H, Wang H, Chen H, Sun L. COQ2 mutation associated isolated nephropathy in two siblings from a Chinese pedigree. Ren Fail 2021;43:97-101. [PMID: 33397173 DOI: 10.1080/0886022X.2020.1864402] [Reference Citation Analysis]
8 Ferrer-Cortès X, Font A, Bujan N, Navarro-Sastre A, Matalonga L, Arranz JA, Riudor E, del Toro M, Garcia-Cazorla A, Campistol J, Briones P, Ribes A, Tort F. Protein expression profiles in patients carrying NFU1 mutations. Contribution to the pathophysiology of the disease. J Inherit Metab Dis 2013;36:841-7. [PMID: 23179554 DOI: 10.1007/s10545-012-9565-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
9 Hurko O. Drug development for rare mitochondrial disorders. Neurotherapeutics 2013;10:286-306. [PMID: 23430661 DOI: 10.1007/s13311-013-0179-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
10 Blumkin L, Leshinsky-Silver E, Zerem A, Yosovich K, Lerman-Sagie T, Lev D. Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability. JIMD Rep 2014;12:103-7. [PMID: 24048965 DOI: 10.1007/8904_2013_251] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
11 Wang Y, Oxer D, Hekimi S. Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis. Nat Commun 2015;6:6393. [PMID: 25744659 DOI: 10.1038/ncomms7393] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
12 Imasawa T, Rossignol R. Podocyte energy metabolism and glomerular diseases. Int J Biochem Cell Biol 2013;45:2109-18. [PMID: 23806869 DOI: 10.1016/j.biocel.2013.06.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
13 Monzio Compagnoni G, Di Fonzo A. Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives. Acta Neuropathol Commun 2019;7:113. [PMID: 31300049 DOI: 10.1186/s40478-019-0730-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
14 Monzio Compagnoni G, Di Fonzo A, Corti S, Comi GP, Bresolin N, Masliah E. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease. Mol Neurobiol 2020;57:2959-80. [PMID: 32445085 DOI: 10.1007/s12035-020-01926-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
15 Goldstein A, Bhatia P, Vento JM. Update on nuclear mitochondrial genes and neurologic disorders. Semin Pediatr Neurol 2012;19:181-93. [PMID: 23245551 DOI: 10.1016/j.spen.2012.09.005] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Zechner J, Britza SM, Farrington R, Byard RW, Musgrave IF. Flavonoid-statin interactions causing myopathy and the possible significance of OATP transport, CYP450 metabolism and mevalonate synthesis. Life Sci 2021;291:119975. [PMID: 34560084 DOI: 10.1016/j.lfs.2021.119975] [Reference Citation Analysis]
17 Botham KM, Napolitano M, Bravo E. The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression. Nutrients. 2015;7:9834-9846. [PMID: 26633474 DOI: 10.3390/nu7125501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
18 Yubero D, Montero R, Ramos M, Neergheen V, Navas P, Artuch R, Hargreaves I. Determination of urinary coenzyme Q 10 by HPLC with electrochemical detection: Reference values for a paediatric population: Determination of Urinary Coenzyme Q 10. BioFactors 2015;41:424-30. [DOI: 10.1002/biof.1242] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
19 Song CC, Hong Q, Geng XD, Wang X, Wang SQ, Cui SY, Guo MD, Li O, Cai GY, Chen XM, Wu D. New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient. Chin Med J (Engl) 2018;131:2666-75. [PMID: 30425193 DOI: 10.4103/0366-6999.245158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
20 Payet LA, Leroux M, Willison JC, Kihara A, Pelosi L, Pierrel F. Mechanistic Details of Early Steps in Coenzyme Q Biosynthesis Pathway in Yeast. Cell Chem Biol 2016;23:1241-50. [PMID: 27693056 DOI: 10.1016/j.chembiol.2016.08.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
21 Yen HC, Liu CC, Kan CC, Chen CS, Wei HR. Suppression of coenzyme Q10 levels and the induction of multiple PDSS and COQ genes in human cells following oligomycin treatment. Free Radic Res. 2014;48:1125-1134. [PMID: 25002068 DOI: 10.3109/10715762.2014.936865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
22 Coppadoro A, Berra L, Kumar A, Pinciroli R, Yamada M, Schmidt UH, Bittner EA, Kaneki M. Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study. J Crit Care 2013;28:571-6. [PMID: 23618779 DOI: 10.1016/j.jcrc.2013.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, LePichon JB, Miller NA, Thiffault I, Dinwiddie DL, Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zuccarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med 2014;6:265ra168. [PMID: 25473036 DOI: 10.1126/scitranslmed.3010076] [Cited by in Crossref: 315] [Cited by in F6Publishing: 290] [Article Influence: 45.0] [Reference Citation Analysis]
24 Wang Y, Hekimi S. Minimal mitochondrial respiration is required to prevent cell death by inhibition of mTOR signaling in CoQ-deficient cells. Cell Death Discov 2021;7:201. [PMID: 34349107 DOI: 10.1038/s41420-021-00591-0] [Reference Citation Analysis]
25 Licitra F, Puccio H. An overview of current mouse models recapitulating coenzyme q10 deficiency syndrome. Mol Syndromol 2014;5:180-6. [PMID: 25126051 DOI: 10.1159/000362942] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
26 Turner RM, Pirmohamed M. Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components. J Clin Med 2019;9:E22. [PMID: 31861911 DOI: 10.3390/jcm9010022] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 18.0] [Reference Citation Analysis]
27 Schottlaender LV, Bettencourt C, Kiely AP, Chalasani A, Neergheen V, Holton JL, Hargreaves I, Houlden H. Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients. PLoS One 2016;11:e0149557. [PMID: 26894433 DOI: 10.1371/journal.pone.0149557] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
28 Tort F, Ferrer-Cortès X, Thió M, Navarro-Sastre A, Matalonga L, Quintana E, Bujan N, Arias A, García-Villoria J, Acquaviva C, Vianey-Saban C, Artuch R, García-Cazorla À, Briones P, Ribes A. Mutations in the lipoyltransferase LIPT1 gene cause a fatal disease associated with a specific lipoylation defect of the 2-ketoacid dehydrogenase complexes. Hum Mol Genet 2014;23:1907-15. [PMID: 24256811 DOI: 10.1093/hmg/ddt585] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
29 Nochi Z, Olsen RKJ, Gregersen N. Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms. J Inherit Metab Dis 2017;40:641-55. [DOI: 10.1007/s10545-017-0047-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
30 González-Mariscal I, Martín-Montalvo A, Ojeda-González C, Rodríguez-Eguren A, Gutiérrez-Ríos P, Navas P, Santos-Ocaña C. Balanced CoQ6 biosynthesis is required for lifespan and mitophagy in yeast. Microb Cell 2017;4:38-51. [PMID: 28357388 DOI: 10.15698/mic2017.02.556] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
31 Arenas‐jal M, Suñé‐negre JM, García‐montoya E. Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges. Comprehensive Reviews in Food Science and Food Safety 2020;19:574-94. [DOI: 10.1111/1541-4337.12539] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
32 Schiff M, Bénit P, Jacobs HT, Vockley J, Rustin P. Therapies in inborn errors of oxidative metabolism. Trends Endocrinol Metab 2012;23:488-95. [PMID: 22633959 DOI: 10.1016/j.tem.2012.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
33 Kumari S, Mehta SL, Milledge GZ, Huang X, Li H, Li PA. Ubisol-Q10 Prevents Glutamate-Induced Cell Death by Blocking Mitochondrial Fragmentation and Permeability Transition Pore Opening. Int J Biol Sci 2016;12:688-700. [PMID: 27194946 DOI: 10.7150/ijbs.13589] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
34 Pshenichnyuk SA, Modelli A, Komolov AS. Interconnections between dissociative electron attachment and electron-driven biological processes. International Reviews in Physical Chemistry 2018;37:125-70. [DOI: 10.1080/0144235x.2018.1461347] [Cited by in Crossref: 11] [Article Influence: 2.8] [Reference Citation Analysis]
35 Selim LA, Hassaan H. Mitochondrial Diseases as Model of Neurodegeneration. In: El-khamisy S, editor. Personalised Medicine. Cham: Springer International Publishing; 2017. pp. 129-55. [DOI: 10.1007/978-3-319-60733-7_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
36 Takahashi H, Shimoda K. Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy. World J Neurol 2014; 4(1): 1-6 [DOI: 10.5316/wjn.v4.i1.1] [Reference Citation Analysis]
37 Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschké P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, Kari JA, Evans J, Bierzynska A, Saleem MA, Böckenhauer D, Kleta R, El Desoky S, Hacihamdioglu DO, Gok F, Washburn J, Wiggins RC, Choi M, Lifton RP, Levy S, Han Z, Salviati L, Prokisch H, Williams DS, Pollak M, Clarke CF, Pei Y, Antignac C, Hildebrandt F. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest 2013;123:5179-89. [PMID: 24270420 DOI: 10.1172/JCI69000] [Cited by in Crossref: 208] [Cited by in F6Publishing: 138] [Article Influence: 23.1] [Reference Citation Analysis]
38 Wang Y, Smith C, Parboosingh JS, Khan A, Innes M, Hekimi S. Pathogenicity of two COQ7 mutations and responses to 2,4-dihydroxybenzoate bypass treatment. J Cell Mol Med 2017;21:2329-43. [PMID: 28409910 DOI: 10.1111/jcmm.13154] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
39 Baruteau J, Hargreaves I, Krywawych S, Chalasani A, Land JM, Davison JE, Kwok MK, Christov G, Karimova A, Ashworth M, Anderson G, Prunty H, Rahman S, Grünewald S. Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism. Mitochondrion 2014;17:150-6. [PMID: 25010387 DOI: 10.1016/j.mito.2014.07.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
40 López LC, Luna-Sánchez M, García-Corzo L, Quinzii CM, Hirano M. Pathomechanisms in coenzyme q10-deficient human fibroblasts. Mol Syndromol 2014;5:163-9. [PMID: 25126049 DOI: 10.1159/000360494] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
41 Chen S, Liu C, Yen H. Detection of suppressed maturation of the human COQ5 protein in the mitochondria following mitochondrial uncoupling by an antibody recognizing both precursor and mature forms of COQ5. Mitochondrion 2013;13:143-52. [DOI: 10.1016/j.mito.2013.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
42 Schon EA. Bioenergetics through thick and thin. Science 2018;362:1114-5. [PMID: 30523097 DOI: 10.1126/science.aav7629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Manzar H, Abdulhussein D, Yap TE, Cordeiro MF. Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain. Int J Mol Sci 2020;21:E9299. [PMID: 33291255 DOI: 10.3390/ijms21239299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
44 Goldstein AC, Bhatia P, Vento JM. Mitochondrial disease in childhood: nuclear encoded. Neurotherapeutics 2013;10:212-26. [PMID: 23516041 DOI: 10.1007/s13311-013-0185-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
45 Ling T, Law C, Yan K, Fong N, Wong K, Lee K, Chu WC, Brea-calvo G, Lam C. Clinical whole-exome sequencing reveals a common pathogenic variant in patients with CoQ10 deficiency: An underdiagnosed cause of mitochondriopathy. Clinica Chimica Acta 2019;497:88-94. [DOI: 10.1016/j.cca.2019.07.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Barsottini OG, Pedroso JL, Martins CR Jr, França MC Jr, Albernaz PM. Deafness and Vestibulopathy in Cerebellar Diseases: a Practical Approach. Cerebellum 2019;18:1011-6. [PMID: 31154624 DOI: 10.1007/s12311-019-01042-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
47 Woerner AC, Vockley J. Mitochondrial Disease and Coenzyme Q10 Deficiency: Commentary. J Pediatr 2021;228:14-15.e1. [PMID: 32966804 DOI: 10.1016/j.jpeds.2020.09.037] [Reference Citation Analysis]
48 Gomes F, Tahara EB, Busso C, Kowaltowski AJ, Barros MH. nde1 deletion improves mitochondrial DNA maintenance in Saccharomyces cerevisiae coenzyme Q mutants. Biochem J 2013;449:595-603. [PMID: 23116202 DOI: 10.1042/BJ20121432] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
49 Yen HC, Liu YC, Kan CC, Wei HJ, Lee SH, Wei YH, Feng YH, Chen CW, Huang CC. Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency. Biochim Biophys Acta 2016;1860:1864-76. [PMID: 27155576 DOI: 10.1016/j.bbagen.2016.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
50 Tsuganezawa K, Sekimata K, Nakagawa Y, Utata R, Nakamura K, Ogawa N, Koyama H, Shirouzu M, Fukami T, Kita K, Tanaka A. Identification of small molecule inhibitors of human COQ7. Bioorg Med Chem 2020;28:115182. [PMID: 31753803 DOI: 10.1016/j.bmc.2019.115182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Montero R, Grazina M, López-gallardo E, Montoya J, Briones P, Navarro-sastre A, Land JM, Hargreaves IP, Artuch R, del Mar O'callaghan M, Jou C, Jimenez C, Buján N, Pineda M, García-cazorla A, Nascimento A, Perez-dueñas B, Ruiz-pesini E, Fratter C, Salviati L, Simões M, Mendes C, Santos MJ, Diogo L, Garcia P, Navas P. Coenzyme Q10 deficiency in mitochondrial DNA depletion syndromes. Mitochondrion 2013;13:337-41. [DOI: 10.1016/j.mito.2013.04.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
52 Shi TJ, Zhang MD, Zeberg H, Nilsson J, Grünler J, Liu SX, Xiang Q, Persson J, Fried KJ, Catrina SB, Watanabe M, Arhem P, Brismar K, Hökfelt TG. Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proc Natl Acad Sci U S A 2013;110:690-5. [PMID: 23267110 DOI: 10.1073/pnas.1220794110] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
53 Abdelhakim AH, Dharmadhikari AV, Ragi SD, de Carvalho JRL Jr, Xu CL, Thomas AL, Buchovecky CM, Mansukhani MM, Naini AB, Liao J, Jobanputra V, Maumenee IH, Tsang SH. Compound heterozygous inheritance of two novel COQ2 variants results in familial coenzyme Q deficiency. Orphanet J Rare Dis 2020;15:320. [PMID: 33187544 DOI: 10.1186/s13023-020-01600-8] [Reference Citation Analysis]
54 Braga Neto P, Pedroso JL, Kuo SH, Marcondes Junior CF, Teive HA, Barsottini OG. Current concepts in the treatment of hereditary ataxias. Arq Neuropsiquiatr 2016;74:244-52. [PMID: 27050855 DOI: 10.1590/0004-282X20160038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
55 Lohman DC, Forouhar F, Beebe ET, Stefely MS, Minogue CE, Ulbrich A, Stefely JA, Sukumar S, Luna-Sánchez M, Jochem A, Lew S, Seetharaman J, Xiao R, Wang H, Westphall MS, Wrobel RL, Everett JK, Mitchell JC, López LC, Coon JJ, Tong L, Pagliarini DJ. Mitochondrial COQ9 is a lipid-binding protein that associates with COQ7 to enable coenzyme Q biosynthesis. Proc Natl Acad Sci U S A 2014;111:E4697-705. [PMID: 25339443 DOI: 10.1073/pnas.1413128111] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 10.4] [Reference Citation Analysis]
56 Busso C, Ferreira-júnior JR, Paulela JA, Bleicher L, Demasi M, Barros MH. Coq7p relevant residues for protein activity and stability. Biochimie 2015;119:92-102. [DOI: 10.1016/j.biochi.2015.10.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
57 Du J, Wang T, Huang P, Cui S, Gao C, Lin Y, Fu R, Shen J, He Y, Tan Y, Chen S. Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy. Parkinsonism Relat Disord 2018;57:58-62. [PMID: 30093363 DOI: 10.1016/j.parkreldis.2018.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Romero-Moya D, Santos-Ocaña C, Castaño J, Garrabou G, Rodríguez-Gómez JA, Ruiz-Bonilla V, Bueno C, González-Rodríguez P, Giorgetti A, Perdiguero E, Prieto C, Moren-Nuñez C, Fernández-Ayala DJ, Victoria Cascajo M, Velasco I, Canals JM, Montero R, Yubero D, Jou C, López-Barneo J, Cardellach F, Muñoz-Cánoves P, Artuch R, Navas P, Menendez P. Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q10 Deficiency. Stem Cells 2017;35:1687-703. [PMID: 28472853 DOI: 10.1002/stem.2634] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
59 Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci. 2012;322:254-262. [PMID: 22669122 DOI: 10.1016/j.jns.2012.05.030] [Cited by in Crossref: 441] [Cited by in F6Publishing: 413] [Article Influence: 44.1] [Reference Citation Analysis]
60 Zhang Y, Liao X, Jiang Y, Lv X, Yu Y, Dai Q, Ao L, Tao L, Peng Z. Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report. BMC Nephrol 2021;22:11. [PMID: 33413146 DOI: 10.1186/s12882-020-02208-7] [Reference Citation Analysis]
61 Garone C, Minczuk M, Alcázar-fabra M, Trevisson E, Brea-calvo G. Clinical syndromes associated with Coenzyme Q10 deficiency. Essays in Biochemistry 2018;62:377-98. [DOI: 10.1042/ebc20170107] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
62 Laredj LN, Licitra F, Puccio HM. The molecular genetics of coenzyme Q biosynthesis in health and disease. Biochimie 2014;100:78-87. [PMID: 24355204 DOI: 10.1016/j.biochi.2013.12.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
63 Barcelos IP, Haas RH. CoQ10 and Aging. Biology (Basel) 2019;8:E28. [PMID: 31083534 DOI: 10.3390/biology8020028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
64 Emmanuele V, López LC, Berardo A, Naini A, Tadesse S, Wen B, D’Agostino E, Solomon M, DiMauro S, Quinzii C. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol. 2012;69:978-983. [PMID: 22490322 DOI: 10.1001/archneurol.2012.206] [Cited by in Crossref: 140] [Cited by in F6Publishing: 117] [Article Influence: 14.0] [Reference Citation Analysis]
65 Paredes-fuentes AJ, Oliva C, Montero R, Alcaide P, Ruijter GJG, García-villoria J, Ruiz-sala P, Artuch R. Technical Aspects of Coenzyme Q10 Analysis: Validation of a New HPLC-ED Method. Antioxidants 2022;11:528. [DOI: 10.3390/antiox11030528] [Reference Citation Analysis]
66 van Diemen MP, Berends CL, Akram N, Wezel J, Teeuwisse WM, Mik BG, Kan HE, Webb A, Beenakker JWM, Groeneveld GJ. Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology study. European Journal of Pharmacology 2017;815:290-7. [DOI: 10.1016/j.ejphar.2017.09.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
67 Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, Fernández Vega A, de la Mata M, Delgado Pavón A, de Miguel M, Pérez Calero C, Villanueva Paz M, Cotán D, Sánchez-Alcázar JA. Coenzyme q10 therapy. Mol Syndromol 2014;5:187-97. [PMID: 25126052 DOI: 10.1159/000360101] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 9.1] [Reference Citation Analysis]
68 Komlosi K, Diederich S, Fend-Guella DL, Bartsch O, Winter J, Zechner U, Beck M, Meyer P, Schweiger S. Targeted next-generation sequencing analysis in couples at increased risk for autosomal recessive disorders. Orphanet J Rare Dis 2018;13:23. [PMID: 29373990 DOI: 10.1186/s13023-018-0763-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
69 Justine Perrin R, Rousset-Rouvière C, Garaix F, Cano A, Conrath J, Boyer O, Tsimaratos M. COQ6 mutation in patients with nephrotic syndrome, sensorineural deafness, and optic atrophy. JIMD Rep 2020;54:37-44. [PMID: 32685349 DOI: 10.1002/jmd2.12068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 McInnes J. Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) 2013;10:63. [PMID: 24499129 DOI: 10.1186/1743-7075-10-63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
71 Hashemi SS, Zare-Abdollahi D, Bakhshandeh MK, Vafaee A, Abolhasani S, Inanloo Rahatloo K, DanaeeFard F, Farboodi N, Rohani M, Alavi A. Clinical spectrum in multiple families with primary COQ10 deficiency. Am J Med Genet A 2021;185:440-52. [PMID: 33215859 DOI: 10.1002/ajmg.a.61983] [Reference Citation Analysis]